Morgan Stanley raised the firm’s price target on Intuitive Surgical to $285 from $265 and keeps an Equal Weight rating on the shares. The firm expects the quarter’s "strong" procedure and placement results will drive a rally in the stock, but also thinks the company’s opportunities are priced into shares given the current valuation. However, it adds that procedure growth upside was "impressive" in Q1 and notes its estimates have moved higher.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on ISRG:
- Intuitive Surgical price target raised to $315 from $300 at BofA
- Intuitive Surgical price target raised to $300 from $250 at Mizuho
- Intuitive Surgical price target raised to $310 from $289 at Wells Fargo
- Intuitive Rises after Q1 Results Beat Estimates
- Intuitive Surgical price target raised to $323 from $270 at Raymond James